HYRNUO
BAYER HEALTHCARE · SEVABERTINIB
Open FDA's page for this record- Application number
- NDA219972
- Sponsor name
- BAYER HEALTHCARE
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20251119
- Review priority
- PRIORITY
- Submission class code
- TYPE 1
- Submission class code description
- Type 1 - New Molecular Entity
- Submission property type
- Code
- Orphan
- Application docs
- ID
- 84233
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219972s000lblCorrected.pdf
- Date
- 20251120
- Type
- Label
- ID
- 84246
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/219972Orig1s000correctedltr.pdf
- Date
- 20251121
- Type
- Letter
- ID
- 84430
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/219972Orig1s000TOC.html
- Date
- 20251216
- Type
- Review
- Submission type
- SUPPL
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260909
- Review priority
- PRIORITY
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Submission property type
- Code
- Orphan
- Application docs
- ID
- 87178
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/219972s001lbl.pdf
- Date
- 20260910
- Type
- Label
- ID
- 87179
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/219972Orig1s001ltr.pdf
- Date
- 20260910
- Type
- Letter
- Products
- Product number
- 001
- Reference drug
- Yes
- Brand name
- HYRNUO
- Reference standard
- Yes
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- SEVABERTINIB
- Strength
- 10MG
